Compare Organon & Co. Common Stock (OGN) vs Warner Music Group Corp (WMG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Organon & Co. Common Stock vs Warner Music Group Corp — how do they compare? Organon & Co. Common Stock trades at $13.73 (market cap $3.61B), while Warner Music Group Corp trades at $29.07 (market cap $15.12B). The key difference: Warner Music Group Corp is far larger — about 4.2× Organon & Co. Common Stock's market cap, and Warner Music Group Corp pays the higher dividend (2.77%). Which is the better fit depends on your goals — on Pluang, investors hold Organon & Co. Common Stock for 0 Days and Warner Music Group Corp for 97 Days on average.
| OGN | WMG | |
|---|---|---|
Market Cap | $3.61B | $15.12B |
Volume | 1,808,049 | 1,727,670 |
Sector | Health | Media |
52-Week High | $13.81 | $34.72 |
52-Week Low | $5.70 | $23.65 |
Typical Hold Time | 0 Days | 97 Days |
Enterprise Value | $11.03B | $19.42B |
Dividend Yield | 0.58% | 2.77% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Organon (OGN) trades at $13.77, showing no change in the latest session. The stock demonstrates strong profitability with 52.68% gross margins and 24.04% ROE, though recent quarterly earnings have missed expectations. Valuation appears reasonable with P/E of 17.65 and P/S of 0.59. The company shows positive cash flow trends with 2026 projections indicating $533M net cash flow. Recent FDA developments for MIUDELLA and VTAMA products highlight ongoing pipeline progress.
OGN presents a mixed outlook with solid fundamentals offset by earnings misses. The healthcare company's improving cash flow and product pipeline offer potential upside, but investor sentiment remains divided with analysts showing cautious optimism. Key risks include execution challenges and competitive pressures in the pharmaceutical sector.
Warner Music Group (WMG) trades at $28.91, up 0.91% on the day, with a bullish technical signal from moving averages. The stock shows strong analyst support with a consensus price target of $39.50, representing significant upside. Recent earnings have beaten expectations in two of the last three quarters, with Q3 2026 results pending. The company maintains robust profitability with a 45.77% gross margin and 9.2% net margin, while revenue growth continues steadily from $6.71B in 2025 to a projected $7.3B in 2026.
WMG presents a compelling investment case with strong fundamentals, positive analyst sentiment, and strategic positioning in the evolving music industry, particularly through AI partnerships. However, risks include recent leadership changes, ongoing copyright litigation, and valuation metrics that appear elevated relative to historical norms. The stock's current price near recent highs suggests limited near-term upside without further positive catalysts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Organon & Co. Common Stock
Organon & Co. is a global healthcare company focused on women's health, biosimilars, and established brands, spun off from Merck & Co. in 2021. Its portfolio of more than 70 medicines includes contraception and fertility therapies, immunology and oncology biosimilars, and treatments in cardiovascular, respiratory, and dermatology, distributed in over 140 countries.
Read more on OGN →About Warner Music Group Corp
Warner Music Group is the third largest of the three major global record labels, with Vivendi's Universal Music in first and Sony Music in second. Warner's larger segment, recorded music, consists of iconic labels like Atlantic Records, Warner Records, and Parlophone Records and popular artists such as Ed Sheeran, Cardi B, Dua Lipa, and Blake Shelton. Warner Chappell, the firm's publishing arm, is the home to over 65,000 composers and songwriters with over a million copyrights represented. Warner is controlled by Access Industries, which owns an 84% economic interest and 99% of voting rights.
Read more on WMG →
